BETA
Start SIP
Invest Now
Start SIP in BETA
Performance
- Low
- ₹1,489
- High
- ₹1,554
- 52 Week Low
- ₹1,430
- 52 Week High
- ₹2,000
- Open Price₹1,546
- Previous Close₹1,554
- Volume6,068
- 50 DMA₹1,618.88
- 100 DMA₹1,673.33
- 200 DMA₹1,705.39
Investment Returns
- Over 1 Month -5.5%
- Over 3 Month -16.51%
- Over 6 Month -11.56%
- Over 1 Year -14.98%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,517
- P/B Ratio
- 6.9
- Average True Range
- 82.65
- EPS
- 45.36
- Dividend Yield
- 0
- MACD Signal
- -18.42
- RSI
- 39.62
- MFI
- 32.2
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,502.90
-50.9
(-3.28%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,571.92
- 50 Day
- ₹1,618.88
- 100 Day
- ₹1,673.33
- 200 Day
- ₹1,705.39
Resistance and Support
1515.3
- R3 1,606.00
- R2 1,579.90
- R1 1,541.40
- S1 1,476.80
- S2 1,450.70
- S3 1,412.20
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-09 | Others | To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-02-05 | Issue of Bonus & Others | To consider other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,502 As on 26 January, 2026 | 00:26
The Market Cap of Beta Drugs is ₹1517.1 Cr As on 26 January, 2026 | 00:26
The P/E ratio of Beta Drugs is As on 26 January, 2026 | 00:26
The PB ratio of Beta Drugs is 6.9 As on 26 January, 2026 | 00:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.